Recent advances in non-invasive prenatal DNA diagnosis through analysis of maternal blood

Journal of Obstetrics and Gynaecology Research

Volumn 33, Issue 6, 2007, Pages 747-764

  Sekizawa, Akihiko ^a   Purwosunu, Yuditiya ^a   Matsuoka, Ryu ^a   Koide, Keiko ^a   Okazaki, Shiho ^a   Farina, Antonio ^a   Saito, Hiroshi ^a   Okai, Takashi ^a  

^a SHOWA UNIVERSITY   (Japan)

Author keywords

Cell free DNA; Fetal cell; Maternal blood; Non invasive prenatal diagnosis; Nucleated erythrocyte

Indexed keywords

LECTIN;

ANEUPLOIDY; BLOOD GROUP RHESUS SYSTEM; CELL MATURATION; DENSITY GRADIENT CENTRIFUGATION; DNA DETERMINATION; ERYTHROCYTE; FETUS CELL; FLUORESCENCE ACTIVATED CELL SORTING; GENETIC ANALYSIS; GENETIC DISORDER; GENOTYPE; HYPEREMESIS GRAVIDARUM; INFRARED SPECTROSCOPY; LEUKOCYTE; MATERNAL BLOOD; PLACENTA; POLYMERASE CHAIN REACTION; PREECLAMPSIA; PREMATURE LABOR; PRENATAL DIAGNOSIS; REVIEW; TROPHOBLAST;

ANEUPLOIDY; DNA; FEMALE; FETAL DISEASES; FETUS; GENETIC DISEASES, INBORN; HUMANS; MALE; MATERNAL-FETAL EXCHANGE; PREGNANCY; PRENATAL DIAGNOSIS;

EID: 36048942020     PISSN: 13418076     EISSN: 14470756     Source Type: Journal    
DOI: 10.1111/j.1447-0756.2007.00652.x     Document Type: Review

References (181)

1. Harper P. Practical Genetic Counseling, 5th edn. Oxford : Butterworth-Heinemann, 1998.
2. Kuliev AM, Modell B, Jackson L et al. Risk evaluation of CVS. Prenat Diagn 1993 13 : 197 209.
3. Firth HV, Boyd PA, Chamberlain PF, MacKenzie IZ, Morriss-Kay GM, Huson SM. Analysis of limb reduction defects in babies exposed to chorionic villus sampling [see comments]. Lancet 1994 343 : 1069 1071.
4. Wald NJ, Cuckle HS, Densem JW et al. Maternal serum screening for Down's syndrome in early pregnancy. BMJ 1988 297 : 883 887.
5. Wald NJ, Densem JW, George L, Muttukrishna S, Knight PG. Prenatal screening for Down's syndrome using inhibin-A as a serum marker. (Published erratum appears in Prenat Diagn 1997; 17: 285-290.) Prenat Diagn 1996 16 : 143 153.
6. Snijders RJ, Noble P, Sebire N, Souka A, Nicolaides KH. UK multicentre project on assessment of risk of trisomy 21 by maternal age and fetal nuchal-translucency thickness at 10-14 weeks of gestation. Fetal Medicine Foundation First Trimester Screening Group [see comments]. Lancet 1998 352 : 343 346.
7. Cicero S, Curcio P, Papageorghiou A, Sonek J, Nicolaides K. Absence of nasal bone in fetuses with trisomy 21 at 11-14 weeks of gestation: an observational study. Lancet 2001 358 : 1665 1667.
8. Cicero S, Avgidou K, Rembouskos G, Kagan KO, Nicolaides KH. Nasal bone in first-trimester screening for trisomy 21. Am J Obstet Gynecol 2006 195 : 109 114.
9. Mandel P, Metais P. Les acides nucleiques du plasma sanguin chez l'homme. CR Acad Sci Paris 1948 142 : 241 243.
10. Tan EM, Schur PH, Carr RI, Kunkel HG. Deoxyribonucleic acid (DNA) and antibodies to DNA in the serum of patients with systemic lupus erythematosus. J Clin Invest 1966 45 : 1732 1740.
11. Leon SA, Ehrlich GE, Shapiro B, Labbate VA. Free DNA in the serum of rheumatoid arthritis patients. J Rheumatol 1977 4 : 139 143.
12. Leon SA, Shapiro B, Sklaroff DM, Yaros MJ. Free DNA in the serum of cancer patients and the effect of therapy. Cancer Res 1977 37 : 646 650.
13. Nawroz H, Koch W, Anker P, Stroun M, Sidransky D. Microsatellite alterations in serum DNA of head and neck cancer patients. Nat Med 1996 2 : 1035 1037.
14. Chen XQ, Stroun M, Magnenat JL et al. Microsatellite alterations in plasma DNA of small cell lung cancer patients. Nat Med 1996 2 : 1033 1035.
15. Lo YM, Corbetta N, Chamberlain PF et al. Presence of fetal DNA in maternal plasma and serum. Lancet 1997 350 : 485 487.
16. Lo YM, Tein MS, Lau TK et al. Quantitative analysis of fetal DNA in maternal plasma and serum: implications for noninvasive prenatal diagnosis. Am J Hum Genet 1998 62 : 768 775.
17. Sekizawa A, Kondo T, Iwasaki M et al. Accuracy of fetal gender determination by analysis of DNA in maternal plasma. Clin Chem 2001 47 : 1856 1858.
18. Lo YM, Zhang J, Leung TN, Lau TK, Chang AM, Hjelm NM. Rapid clearance of fetal DNA from maternal plasma. Am J Hum Genet 1999 64 : 218 224.
19. Lo YM, Hjelm NM, Fidler C et al. Prenatal diagnosis of fetal RhD status by molecular analysis of maternal plasma. N Engl J Med 1998 339 : 1734 1738.
20. Tang NL, Leung TN, Zhang J, Lau TK, Lo YM. Detection of fetal-derived paternally inherited X-chromosome polymorphisms in maternal plasma. Clin Chem 1999 45 : 2033 2035.
21. Stanghellini I, Bertorelli R, Capone L et al. Quantitation of fetal DNA in maternal serum during the first trimester of pregnancy by the use of a DAZ repetitive probe. Mol Hum Reprod 2006 12 : 587 591.
22. Hromadnikova I, Houbova B, Hridelova D et al. Replicate real-time PCR testing of DNA in maternal plasma increases the sensitivity of non-invasive fetal sex determination. Prenat Diagn 2003 23 : 235 238.
23. Hyett JA, Gardener G, Stojilkovic-Mikic T et al. Reduction in diagnostic and therapeutic interventions by non-invasive determination of fetal sex in early pregnancy. Prenat Diagn 2005 25 : 1111 1116.
24. Chi C, Hyett JA, Finning KM, Lee CA, Kadir RA. Non-invasive first trimester determination of fetal gender: a new approach for prenatal diagnosis of haemophilia. BJOG 2006 113 : 239 242.
25. Budka H. Prions and transfusion medicine. Vox Sang 2000 78 (Suppl 2 231 238.
26. Bianchi DW, Avent ND, Costa JM, van der Schoot CE. Noninvasive prenatal diagnosis of fetal Rhesus D: ready for Prime(r) Time. Obstet Gynecol 2005 106 : 841 844.
27. Brojer E, Zupanska B, Guz K, Orzinska A, Kalinska A. Noninvasive determination of fetal RHD status by examination of cell-free DNA in maternal plasma. Transfusion 2005 45 : 1473 1480.
28. Hengstschlager M, Holzl G, Ulm B, Bernaschek G. Raising the sensitivity of fetal RhD typing and sex determination from maternal blood. J Med Genet 1997 34 : 350 351.
29. Van der Schoot CE, Soussan AA, Koelewijn J, Bonsel G, Paget-Christiaens LG, de Haas M. Non-invasive antenatal RHD typing. Transfus Clin Biol 2006 13 : 53 57.
30. Tax MG, van der Schoot CE, van Doorn R, Douglas-Berger L, van Rhenen DJ, Maaskant-vanWijk PA. RHC and RHc genotyping in different ethnic groups. Transfusion 2002 42 : 634 644.
31. Saito H, Sekizawa A, Morimoto T, Suzuki M, Yanaihara T. Prenatal DNA diagnosis of a single-gene disorder from maternal plasma. Lancet 2000 356 : 1170.
32. Shiang R, Thompson L, Zhu Y et al. Mutations in the transmembrane domain of FGFR3 cause the most common genetic form of dwarfism, achondroplasia. Cell 1994 78 : 335 342.
33. Li Y, Holzgreve W, Page-Christiaens GC, Gille JJ, Hahn S. Improved prenatal detection of a fetal point mutation for achondroplasia by the use of size-fractionated circulatory DNA in maternal plasma - case report. Prenat Diagn 2004 24 : 896 898.
34. Amicucci P, Gennarelli M, Novelli G, Dallapiccola B. Prenatal diagnosis of myotonic dystrophy using fetal DNA obtained from maternal plasma. Clin Chem 2000 46 : 301 302.
35. Nasis O, Thompson S, Hong T et al. Improvement in sensitivity of allele-specific PCR facilitates reliable noninvasive prenatal detection of cystic fibrosis. Clin Chem 2004 50 : 694 701.
36. Gonzalez-Gonzalez MC, Garcia-Hoyos M, Trujillo MJ et al. Prenatal detection of a cystic fibrosis mutation in fetal DNA from maternal plasma. Prenat Diagn 2002 22 : 946 948.
37. Vrettou C, Traeger-Synodinos J, Tzetis M, Malamis G, Kanavakis E. Rapid screening of multiple beta-globin gene mutations by real-time PCR on the LightCycler: application to carrier screening and prenatal diagnosis of thalassemia syndromes. Clin Chem 2003 49 : 769 776.
38. Li Y, Di Naro E, Vitucci A, Zimmermann B, Holzgreve W, Hahn S. Detection of paternally inherited fetal point mutations for beta-thalassemia using size-fractionated cell-free DNA in maternal plasma. JAMA 2005 293 : 843 849.
39. Chiu RW, Lau TK, Leung TN, Chow KC, Chui DH, Lo YM. Prenatal exclusion of beta thalassaemia major by examination of maternal plasma. Lancet 2002 360 : 998 1000.
40. Chiu RW, Lau TK, Cheung PT, Gong ZQ, Leung TN, Lo YM. Noninvasive prenatal exclusion of congenital adrenal hyperplasia by maternal plasma analysis: a feasibility study. Clin Chem 2002 48 : 778 780.
41. Poon LL, Leung TN, Lau TK, Chow KC, Lo YM. Differential DNA methylation between fetus and mother as a strategy for detecting fetal DNA in maternal plasma. Clin Chem 2002 48 : 35 41.
42. Lo YM, Leung TN, Tein MS et al. Quantitative abnormalities of fetal DNA in maternal serum in preeclampsia. Clin Chem 1999 45 : 184 188.
43. Zhong XY, Holzgreve W, Hahn S. Circulatory fetal and maternal DNA in pregnancies at risk and those affected by preeclampsia. Ann NY Acad Sci 2001 945 : 138 140.
44. Sekizawa A, Jimbo M, Saito H et al. Cell-free fetal DNA in the plasma of pregnant women with severe fetal growth restriction. Am J Obstet Gynecol 2003 188 : 480 484.
45. Caramelli E, Rizzo N, Concu M et al. Cell-free fetal DNA concentration in plasma of patients with abnormal uterine artery Doppler waveform and intrauterine growth restriction - a pilot study. Prenat Diagn 2003 23 : 367 371.
46. Roberts JM, Cooper DW. Pathogenesis and genetics of pre-eclampsia. Lancet 2001 357 : 53 56.
47. Sekizawa A, Yokokawa K, Sugito Y et al. Evaluation of bidirectional transfer of plasma DNA through placenta. Hum Genet 2003 113 : 307 310.
48. Lau TW, Leung TN, Chan LY et al. Fetal DNA clearance from maternal plasma is impaired in preeclampsia. Clin Chem 2002 48 : 2141 2146.
49. Sekizawa A, Farina A, Sugito Y et al. Proteinuria and hypertension are independent factors affecting fetal DNA values: a retrospective analysis of affected and unaffected patients. Clin Chem 2004 50 : 221 224.
50. Sekizawa A, Farina A, Koide K et al. Beta-globin DNA in maternal plasma as a molecular marker of preeclampsia. Prenat Diagn 2004 24 : 697 700.
51. Leung TN, Zhang J, Lau TK, Hjelm NM, Lo YM. Maternal plasma fetal DNA as a marker for preterm labour. Lancet 1998 352 : 1904 1905.
52. Farina A, Sekizawa A, Sugito Y et al. Fetal DNA in maternal plasma as a screening variable for preeclampsia. A preliminary nonparametric analysis of detection rate in low-risk nonsymptomatic patients. Prenat Diagn 2004 24 : 83 86.
53. Farina A, Sekizawa A, Iwasaki M, Matsuoka R, Ichizuka K, Okai T. Total cell-free DNA (beta-globin gene) distribution in maternal plasma at the second trimester: a new prospective for preeclampsia screening. Prenat Diagn 2004 24 : 722 726.
54. Sekizawa A, Sugito Y, Iwasaki M et al. Cell-free fetal DNA is increased in plasma of women with hyperemesis gravidarum. Clin Chem 2001 47 : 2164 2165.
55. Sugito Y, Sekizawa A, Farina A et al. Relationship between severity of hyperemesis gravidarum and fetal DNA concentration in maternal plasma. Clin Chem 2003 49 : 1667 1669.
56. Minagawa M, Narita J, Tada T et al. Mechanisms underlying immunologic states during pregnancy: possible association of the sympathetic nervous system. Cell Immunol 1999 196 : 1 13.
57. Sekizawa A, Jimbo M, Saito H et al. Increased cell-free fetal DNA in plasma of two women with invasive placenta. Clin Chem 2002 48 : 353 354.
58. Jimbo M, Sekizawa A, Sugito Y et al. Placenta increta: postpartum monitoring of plasma cell-free fetal DNA. Clin Chem 2003 49 : 1540 1541.
59. Farina A, LeShane E, Romero R et al. High levels of fetal cell-free DNA in maternal serum: a Risk factor for spontaneous preterm delivery. Am J Obstet Gynecol 2005 193 : 421 425.
60. Lo YM, Lau TK, Zhang J et al. Increased fetal DNA concentrations in the plasma of pregnant women carrying fetuses with trisomy 21. Clin Chem 1999 45 : 1747 1751.
61. Zhong XY, Burk MR, Troeger C, Jackson LR, Holzgreve W, Hahn S. Fetal DNA in maternal plasma is elevated in pregnancies with aneuploid fetuses. Prenat Diagn 2000 20 : 795 798.
62. Farina A, LeShane ES, Lambert-Messerlian GM et al. Evaluation of cell-free fetal DNA as a second-trimester maternal serum marker of Down syndrome pregnancy. Clin Chem 2003 49 : 239 242.
63. Ohashi Y, Miharu N, Honda H, Samura O, Ohama K. Quantitation of fetal DNA in maternal serum in normal and aneuploid pregnancies. Hum Genet 2001 108 : 123 127.
64. Hromadnikova I, Houbova B, Hridelova D et al. Quantitative analysis of DNA levels in maternal plasma in normal and Down syndrome pregnancies. BMC Pregnancy Childbirth 2002 2 : 4.
65. Spencer K, de Kok JB, Swinkels DW. Increased total cell-free DNA in the serum of pregnant women carrying a fetus affected by trisomy 21. Prenat Diagn 2003 23 : 580 583.
66. Sekizawa A, Samura O, Zhen D, Falco V, Farina A, Bianchi DW. Apoptosis in fetal nucleated erythrocytes circulating in maternal blood. Prenat Diagn 2000 20 : 886 889.
67. Kondo T, Sekizawa A, Saito H, Jimbo M, Sugito Y, Okai T. Fate of fetal nucleated erythrocytes circulating in maternal blood: apoptosis is induced by maternal oxygen concentration. Clin Chem 2002 48 : 1618 1620.
68. Fournie GJ, Courtin JP, Laval F et al. Plasma DNA as a marker of cancerous cell death. Investigations in patients suffering from lung cancer and in nude mice bearing human tumours. Cancer Lett 1995 91 : 221 227.
69. Giacona MB, Ruben GC, Iczkowski KA, Roos TB, Porter DM, Sorenson GD. Cell-free DNA in human blood plasma: length measurements in patients with pancreatic cancer and healthy controls. Pancreas 1998 17 : 89 97.
70. Holdenrieder S, Stieber P, Chan LY et al. Cell-free DNA in serum and plasma: comparison of ELISA and quantitative PCR. Clin Chem 2005 51 : 1544 1546.
71. Angert RM, LeShane ES, Lo YM, Chan LY, Delli-Bovi LC, Bianchi DW. Fetal cell-free plasma DNA concentrations in maternal blood are stable 24 hours after collection: analysis of first- and third-trimester samples. Clin Chem 2003 49 : 195 198.
72. Hoesli I, Danek M, Lin D, Li Y, Hahn S, Holzgreve W. Circulating erythroblasts in maternal blood are not elevated before onset of preterm labor. Obstet Gynecol 2002 100 : 992 996.
73. Loke YW, King A. Immunology of human placental implantation: clinical implications of our current understanding. Mol Med Today 1997 3 : 153 159.
74. Ishihara N, Matsuo H, Murakoshi H, Laoag-Fernandez JB, Samoto T, Maruo T. Increased apoptosis in the syncytiotrophoblast in human term placentas complicated by either preeclampsia or intrauterine growth retardation. Am J Obstet Gynecol 2002 186 : 158 166.
75. Ariga H, Ohto H, Busch MP et al. Kinetics of fetal cellular and cell-free DNA in the maternal circulation during and after pregnancy: implications for noninvasive prenatal diagnosis. Transfusion 2001 41 : 1524 1530.
76. Smith SC, Baker PN. Placental apoptosis is increased in post-term pregnancies. Br J Obstet Gynaecol 1999 106 : 861 862.
77. Ohashi Y, Miharu N, Honda H, Samura O, Ohama K. Correlation of fetal DNA and human chorionic gonadotropin concentrations in second-trimester maternal serum. Clin Chem 2002 48 : 386 388.
78. Ng EK, Tsui NB, Lau TK et al. mRNA of placental origin is readily detectable in maternal plasma. Proc Natl Acad Sci USA 2003 100 : 4748 4753.
79. Ng EK, Leung TN, Tsui NB et al. The concentration of circulating corticotropin-releasing hormone mRNA in maternal plasma is increased in preeclampsia. Clin Chem 2003 49 : 727 731.
80. Wataganara T, Metzenbauer M, Peter I, Johnson KL, Bianchi DW. Placental volume, as measured by 3-dimensional sonography and levels of maternal plasma cell-free fetal DNA. Am J Obstet Gynecol 2005 193 : 496 500.
81. Schmorl G. Pathogisch-anatomische untersuchungen uber puerperaleklampsie. Leipzig : Vogel, 1893.
82. Douglas GW, Thomas L, Carr M, Cullen NM, Morris R. Trophoblast in the circulating blood during pregnancy. Am J Obstet Gynecol 1959 78 : 960 973.
83. Benirschke K. Anatomical relationship between fetus and mother. Ann NY Acad Sci 1994 731 : 9 20.
84. Ganshirt-Ahlert D, Basak N, Aidynli K, Holzgreve W. Fetal DNA in uterine vein blood. Obstet Gynecol 1992 80 : 601 603.
85. Covone AE, Mutton D, Johnson PM, Adinolfi M. Trophoblast cells in peripheral blood from pregnant women. Lancet 1984 2 : 841 843.
86. Sargent IL, Choo YS, Redman CW. Isolating and analyzing fetal leukocytes in maternal blood. Ann NY Acad Sci 1994 731 : 147 153.
87. Bertero MT, Camaschella C, Serra A, Bergui L, Caligaris-Cappio F. Circulating 'trophoblast' cells in pregnancy have maternal genetic markers. Prenat Diagn 1988 8 : 585 590.
88. Covone AE, Kozma R, Johnson PM, Latt SA, Adinolfi M. Analysis of peripheral maternal blood samples for the presence of placenta-derived cells using Y-specific probes and McAb H315. Prenat Diagn 1988 8 : 591 607.
89. Henderson KG, Shaw TE, Barrett IJ, Telenius AH, Wilson RD, Kalousek DK. Distribution of mosaicism in human placentae. Hum Genet 1996 97 : 650 654.
90. Goldberg JD, Wohlferd MM. Incidence and outcome of chromosomal mosaicism found at the time of chorionic villus sampling. Am J Obstet Gynecol 1997 176 : 1349 1352 discussion 1352 1353.
91. Mueller UW, Hawes CS, Wright AE et al. Isolation of fetal trophoblast cells from peripheral blood of pregnant women. Lancet 1990 336 : 197 200.
92. Hawes CS, Suskin HA, Kalionis B et al. Detection of paternally inherited mutations for beta-thalassemia in trophoblast isolated from peripheral maternal blood. Ann NY Acad Sci 1994 731 : 181 185.
93. Tse DB, Anderson P, Goldbard S, Gown AM, Hawes CS, Donnenfeld A. Characterization of trophoblast-reactive monoclonal antibodies by flow cytometry and their application for fetal cell isolation. Ann NY Acad Sci 1994 731 : 162 169.
94. Walknowska J, Conte FA, Grumbach MM. Practical and theoretical implications of fetal-maternal lymphocyte transfer. Lancet 1969 1 : 1119 1122.
95. Grosset L, Barrelet V, Odartchenko N. Antenatal fetal sex determination from maternal blood during early pregnancy. Am J Obstet Gynecol 1974 120 : 60 63.
96. Schroder J, De la Chapelle A. Fetal lymphocytes in the maternal blood. Blood 1972 39 : 153 162.
97. Siebers JW, Knauf I, Hillemanns HG. Antenatal sex determination in blood from pregnant women. Humangenetik 1975 28 : 273 280.
98. Parks DR, Herzenberg LA. Fetal cells from maternal blood: their selection and prospects for use in prenatal diagnosis. Methods Cell Biol 1982 26 : 277 295.
99. Schindler AM, Martin-du-Pan R. Prenatal diagnosis of fetal lymphocytes in the maternal blood. Obstet Gynecol 1972 40 : 340 346.
100. Takahara H, Kadotani T, Kusumi I, Makino S. Some critical aspects on prenatal diagnosis of sex in leucocyte cultures from pregnant women. Proc Jpn Acad 1972 48 : 603 607.
101. Whang-Peng J, Leikin S, Harris C, Lee E, Sites J. The transplacental passage of fetal leukocytes into the maternal blood. Proc Soc Exp Biol Med 1973 142 : 50 53.
102. Schroder J. Are fetal cells in maternal blood mainly B lymphocytes? Scand J Immunol 1975 4 : 279 285.
103. Schroder J, Schroder E, Cann HM. Fetal cells in the maternal blood. Lack of response of fetal cells in maternal blood to mitogens and mixed leukocyte culture. Hum Genet 1977 38 : 91 97.
104. Herzenberg LA, Bianchi DW, Schroder J, Cann HM, Iverson GM. Fetal cells in the blood of pregnant women: detection and enrichment by fluorescence- activated cell sorting. Proc Natl Acad Sci USA 1979 76 : 1453 1455.
105. Iverson GM, Bianchi DW, Cann HM, Herzenberg LA. Detection and isolation of fetal cells from maternal blood using the flourescence-activated cell sorter (FACS). Prenat Diagn 1981 1 : 61 73.
106. Tharapel AT, Jaswaney VL, Dockter ME et al. Inability to detect fetal metaphases in flow-sorted lymphocyte cultures based on maternal-fetal HLA differences. Fetal Diagn Ther 1993 8 : 95 101.
107. Schroder J, Tiilikainen A, De la Chapelle A. Fetal leukocytes in the maternal circulation after delivery. I. Cytological aspects. Transplantation 1974 17 : 346 354.
108. Hsieh TT, Pao CC, Hor JJ, Kao SM. Presence of fetal cells in maternal circulation after delivery. Hum Genet 1993 92 : 204 205.
109. Ciaranfi A, Curchod A, Odartchenko N. [Post-partum survival of fetal lymphocytes in the maternal blood]. Schweiz Med Wochenschr 1977 107 : 134 138. (In French.)
110. Liou JD, Hsieh TT, Pao CC. Presence of cells of fetal origin in maternal circulation of pregnant women. Ann NY Acad Sci 1994 731 : 237 241.
111. Bianchi DW, Zickwolf GK, Weil GJ, Sylvester S, DeMaria MA. Male fetal progenitor cells persist in maternal blood for as long as 27 years postpartum. Proc Natl Acad Sci USA 1996 93 : 705 708.
112. Kleihauer E, Braun H, Betke K. [Demonstration of fetal hemoglobin in erythrocytes of a blood smear.] Klin Wochenschr 1957 35 : 637 638. (In German.)
113. Clayton EM Feldhaus WD, Whitacre FE. Fetal erythrocytes in the maternal circulation of pregnant women. Obstet Gynecol 1964 23 : 915 919.
114. Ganshirt D, Garritsen H, Miny P, Holzgreve W. Fetal cells in maternal circulation throughout gestation. Lancet 1994 343 : 1038 1039.
115. Pearson HA. Life-span of the fetal red blood cell. J Pediatr 1967 70 : 166 171.
116. Bianchi DW, Flint AF, Pizzimenti MF, Knoll JH, Latt SA. Isolation of fetal DNA from nucleated erythrocytes in maternal blood. Proc Natl Acad Sci USA 1990 87 : 3279 3283.
117. Holzgreve W, Garritsen HS, Ganshirt-Ahlert D. Fetal cells in the maternal circulation. J Reprod Med 1992 37 : 410 418.
118. Von Koskull H, Gahmberg N. Fetal erythroblasts from maternal blood identified with 2,3-bisphosphoglycerate (BPG) and in situ hybridization (ISH) using Y-specific probes. Prenat Diagn 1995 15 : 149 154.
119. Wachtel S, Elias S, Price J et al. Fetal cells in the maternal circulation: isolation by multiparameter flow cytometry and confirmation by polymerase chain reaction. Hum Reprod 1991 6 : 1466 1469.
120. Price JO, Elias S, Wachtel SS et al. Prenatal diagnosis with fetal cells isolated from maternal blood by multiparameter flow cytometry. Am J Obstet Gynecol 1991 165 : 1731 1737.
121. Miltenyi S, Muller W, Weichel W, Radbruch A. High gradient magnetic cell separation with MACS. Cytometry 1990 11 : 231 238.
122. Ganshirt-Ahlert D, Borjesson-Stoll R, Burschyk M et al. Detection of fetal trisomies 21 and 18 from maternal blood using triple gradient and magnetic cell sorting. Am J Reprod Immunol 1993 30 : 194 201.
123. Ganshirt-Ahlert D, Pohlschmidt M, Gal A, Miny P, Horst J, Holzgreve W. Ratio of fetal to maternal DNA is less than 1 in 5000 at different gestational ages in maternal blood. Clin Genet 1990 38 : 38 43.
124. Hamada H, Arinami T, Kubo T, Hamaguchi H, Iwasaki H. Fetal nucleated cells in maternal peripheral blood: frequency and relationship to gestational age. Hum Genet 1993 91 : 427 432.
125. Bianchi DW, Williams JM, Sullivan LM, Hanson FW, Klinger KW, Shuber AP. PCR quantitation of fetal cells in maternal blood in normal and aneuploid pregnancies. Am J Hum Genet 1997 61 : 822 829.
126. Hamada H, Arinami T, Sohda S, Hamaguchi H, Kubo T. Mid-trimester fetal sex determination from maternal peripheral blood by fluorescence in situ hybridization without enrichment of fetal cells. Prenat Diagn 1995 15 : 78 81.
127. Slunga-Tallberg A, el-Rifai W, Keinanen M et al. Maternal origin of nucleated erythrocytes in peripheral venous blood of pregnant women. Hum Genet 1995 96 : 53 57.
128. Slunga-Tallberg A, el-Rifai W, Keinanen M et al. Maternal origin of transferrin receptor positive cells in venous blood of pregnant women. Clin Genet 1996 49 : 196 199.
129. de Graaf IM, Jakobs ME, Leschot NJ, Ravkin I, Goldbard S, Hoovers JM. Enrichment, identification and analysis of fetal cells from maternal blood: evaluation of a prenatal diagnosis system. Prenat Diagn 1999 19 : 648 652.
130. Troeger C, Zhong XY, Burgemeister R et al. Approximately half of the erythroblasts in maternal blood are of fetal origin. Mol Hum Reprod 1999 5 : 1162 1165.
131. Lo YM, Morey AL, Wainscoat JS, Fleming KA. Culture of fetal erythroid cells from maternal peripheral blood. Lancet 1994 344 : 264 265.
132. Valerio D, Aiello R, Altieri V, Malato AP, Fortunato A, Canazio A. Culture of fetal erythroid progenitor cells from maternal blood for non-invasive prenatal genetic diagnosis. Prenat Diagn 1996 16 : 1073 1082.
133. Bohmer RM, Johnson KL, Bianchi DW. Fetal and maternal progenitor cells in co-culture respond equally to erythropoietin. Prenat Diagn 2001 21 : 818 823.
134. Campagnoli C, Roberts IA, Kumar S et al. Expandability of haemopoietic progenitors in first trimester fetal and maternal blood: implications for non-invasive prenatal diagnosis. Prenat Diagn 2002 22 : 463 469.
135. Bonney EA, Matzinger P. The maternal immune system's interaction with circulating fetal cells. J Immunol 1997 158 : 40 47.
136. Thomas MR, Williamson R, Craft I, Rodeck CH. The time of appearance, and quantitation, of fetal DNA in the maternal circulation. Ann NY Acad Sci 1994 731 : 217 225.
137. Thomas MR, Williamson R, Craft I, Yazdani N, Rodeck CH. Y chromosome sequence DNA amplified from peripheral blood of women in early pregnancy. Lancet 1994 343 : 413 414.
138. Lo YM, Patel P, Baigent CN et al. Prenatal sex determination from maternal peripheral blood using the polymerase chain reaction. Hum Genet 1993 90 : 483 488.
139. Bianchi DW, Stewart JE, Garber MF, Lucotte G, Flint AF. Possible effect of gestational age on the detection of fetal nucleated erythrocytes in maternal blood. Prenat Diagn 1991 11 : 523 528.
140. Ganshirt D, Borjesson-Stoll R, Burschyk M et al. Successful prenatal diagnosis from maternal blood with magnetic-activated cell sorting. Ann NY Acad Sci 1994 731 : 103 114.
141. Rochelson B, Kaplan C, Guzman E, Arato M, Hansen K, Trunca C. A quantitative analysis of placental vasculature in the third-trimester fetus with autosomal trisomy. Obstet Gynecol 1990 75 : 59 63.
142. Kuhlmann RS, Werner AL, Abramowicz J, Warsof SL, Arrington J, Levy DL. Placental histology in fetuses between 18 and 23 weeks' gestation with abnormal karyotype. Am J Obstet Gynecol 1990 163 : 1264 1270.
143. Sipes SL, Weiner CP, Wenstrom KD, Williamson RA, Grant SS. The association between fetal karyotype and mean corpuscular volume. Am J Obstet Gynecol 1991 165 : 1371 1376.
144. Thilaganathan B, Meher-Homji NJ, Nicolaides KH. Blood transferrin receptor expression in chromosomally abnormal fetuses. Prenat Diagn 1995 15 : 282 284.
145. Zheng YL, Zhen DK, DeMaria MA et al. Search for the optimal fetal cell antibody: results of immunophenotyping studies using flow cytometry. Hum Genet 1997 100 : 35 42.
146. Simpson JL, Elias S. Isolating fetal cells from maternal blood. Advances in prenatal diagnosis through molecular technology. JAMA 1993 270 : 2357 2361.
147. Holzgreve W, Ghezzi F, Di Naro E, Ganshirt D, Maymon E, Hahn S. Disturbed feto-maternal cell traffic in preeclampsia. Obstet Gynecol 1998 91 : 669 672.
148. Nelson JL, Furst DE, Maloney S et al. Microchimerism and HLA-compatible relationships of pregnancy in scleroderma. Lancet 1998 351 : 559 562.
149. DeMaria MA, Zheng YL, Zhen D, Weinschenk NM, Vadnais TJ, Bianchi DW. Improved fetal nucleated erythrocyte sorting purity using intracellular antifetal hemoglobin and Hoechst 33342. Cytometry 1996 25 : 37 45.
150. Sekizawa A, Farina A, Zhen DK et al. Improvement of fetal cell recovery from maternal blood: suitable density gradient for FACS separation. Fetal Diagn Ther 1999 14 : 229 233.
151. Ganshirt-Ahlert D, Burschyk M, Garritsen HS et al. Magnetic cell sorting and the transferrin receptor as potential means of prenatal diagnosis from maternal blood. Am J Obstet Gynecol 1992 166 : 1350 1355.
152. Bigbee WL, Grant SG. Use of allele-specific glycophorin A antibodies to enumerate fetal erythroid cells in maternal circulation. Ann NY Acad Sci 1994 731 : 128 132.
153. Busch J, Huber P, Holtz J, Pfluger E, Radbruch A. Simple and fast 'double-MACS' sorting of fetal erythroblasts from maternal blood for PCR-based paternity analysis. Ann NY Acad Sci 1994 731 : 144 146.
154. Zhen DK, Wang JY, Falco VM et al. Poly-FISH: a technique of repeated hybridizations that improves cytogenetic analysis of fetal cells in maternal blood. Prenat Diagn 1998 18 : 1181 1185.
155. Wang JY, Zhen DK, Falco VM et al. Fetal nucleated erythrocyte recovery: fluorescence activated cell sorting-based positive selection using anti-gamma globin versus magnetic activated cell sorting using anti-CD45 depletion and anti- gamma globin positive selection. Cytometry 2000 39 : 224 230.
156. Sekizawa A, Samura O, Zhen DK, Falco V, Farina A, Bianchi DW. Apoptosis in fetal nucleated erythrocytes circulating in maternal blood. Prenat Diagn 2000 20 : 886 889.
157. Sekizawa A, Samura O, Zhen DK, Falco V, Bianchi DW. Fetal cell recycling: diagnosis of gender and RhD genotype in the same fetal cell retrieved from maternal blood. Am J Obstet Gynecol 1999 181 : 1237 1242.
158. Samura O, Sekizawa A, Zhen DK, Falco VM, Bianchi DW. Comparison of fetal cell recovery from maternal blood using a high density gradient for the initial separation step: 1.090 versus 1.119 g/mL. Prenat Diagn 2000 20 : 281 286.
159. Bianchi DW, Simpson JL, Jackson LG et al. Fetal gender and aneuploidy detection using fetal cells in maternal blood: analysis of NIFTY I data. National Institute of Child Health and Development Fetal Cell Isolation Study. Prenat Diagn 2002 22 : 609 615.
160. Bhat NM, Bieber MM, Teng NN. One-step enrichment of nucleated red blood cells. A potential application in perinatal diagnosis. J Immunol Meth 1993 158 : 277 280.
161. Takabayashi H, Kuwabara S, Ukita T, Ikawa K, Yamafuji K, Igarashi T. Development of non-invasive fetal DNA diagnosis from maternal blood. Prenat Diagn 1995 15 : 74 77.
162. Voullaire L, Ioannou P, Nouri S, Williamson R. Fetal nucleated red blood cells from CVS washings: an aid to development of first trimester non-invasive prenatal diagnosis. Prenat Diagn 2001 21 : 827 834.
163. Troeger C, Holzgreve W, Hahn S. A comparison of different density gradients and antibodies for enrichment of fetal erythroblasts by MACS. Prenat Diagn 1999 19 : 521 526.
164. Prieto B, Alonso R, Paz A et al. Optimization of nucleated red blood cell (NRBC) recovery from maternal blood collected using both layers of a double density gradient. Prenat Diagn 2001 21 : 187 193.
165. Boyer SH, Noyes AN, Boyer ML. Enrichment of erythrocytes of fetal origin from adult-fetal blood mixtures via selective hemolysis of adult blood cells: an aid to antenatal diagnosis of hemoglobinopathies. Blood 1976 47 : 883 897.
166. Hengstschlager M, Bernaschek G. Fetal cells in the peripheral blood of pregnant women express thymidine kinase: a new marker for detection. FEBS Lett 1997 404 : 299 302.
167. Savion S, Carp H, Shepshelovich J et al. Use of antibodies against the human antigen of erythroblasts for the detection of nucleated erythrocytes in the maternal circulation. Biol Neonate 1997 71 : 126 130.
168. Valerio D, Aiello R, Altieri V. Isolation of fetal erythroid cells from maternal blood based on expression of erythropoietin receptors. Mol Hum Reprod 1997 3 : 451 455.
169. Wachtel SS, Sammons D, Manley M et al. Fetal cells in maternal blood: recovery by charge flow separation. Hum Genet 1996 98 : 162 166.
170. Wachtel SS, Sammons D, Twitty G et al. Charge flow separation: quantification of nucleated red blood cells in maternal blood during pregnancy. Prenat Diagn 1998 18 : 455 463.
171. Kitagawa M, Sugiura K, Omi H et al. New technique using galactose-specific lectin for isolation of fetal cells from maternal blood. Prenat Diagn 2002 22 : 17 21.
172. Babochkina T, Mergenthaler S, Lapaire O et al. Evaluation of a soybean lectin-based method for the enrichment of erythroblasts. J Histochem Cytochem 2005 53 : 329 330.
173. Purwosunu Y, Sekizawa A, Farina A et al. Enrichment of NRBC in maternal blood: a more feasible method for noninvasive prenatal diagnosis. Prenat Diagn 2006 26 : 545 547.
174. Zheng YL, Carter NP, Price CM et al. Prenatal diagnosis from maternal blood: simultaneous immunophenotyping and FISH of fetal nucleated erythrocytes isolated by negative magnetic cell sorting. J Med Genet 1993 30 : 1051 1056.
175. Ferguson-Smith MA, Zheng YL, Carter NP. Simultaneous immunophenotyping and FISH on fetal cells from maternal blood. Ann NY Acad Sci 1994 731 : 73 79.
176. Samura O, Pertl B, Sohda S et al. Female fetal cells in maternal blood: use of DNA polymorphisms to prove origin. Hum Genet 2000 107 : 28 32.
177. Babochkina T, Mergenthaler S, De Napoli G et al. Numerous erythroblasts in maternal blood are impervious to fluorescent in situ hybridization analysis, a feature related to a dense compact nucleus with apoptotic character. Haematologica 2005 90 : 740 745.
178. Sekizawa A, Kimura T, Sasaki M, Nakamura S, Kobayashi R, Sato T. Prenatal diagnosis of Duchenne muscular dystrophy using a single fetal nucleated erythrocyte in maternal blood. Neurology 1996 46 : 1350 1353.
179. Watanabe A, Sekizawa A, Taguchi A et al. Prenatal diagnosis of ornithine transcarbamylase deficiency by using a single nucleated erythrocyte from maternal blood. Hum Genet 1998 102 : 611 615.
180. Cheung MC, Goldberg JD, Kan YW. Prenatal diagnosis of sickle cell anaemia and thalassaemia by analysis of fetal cells in maternal blood. Nat Genet 1996 14 : 264 268.
181. Sekizawa A, Purwosunu Y, Farina A et al. Development of noninvasive fetal DNA diagnosis from nucleated erythrocytes circulating in maternal blood. Prenat Diagn 2007 27 : 846 848.